Clinical Trials Browser

Phase 3 × Lymphoma, B-Cell, Marginal Zone × ibrutinib × Clear all

NCT04212013 2025-07-23

A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma

Phase 3 Active not recruiting

Lymphoma, B-Cell, Marginal Zone

NCT01974440 2025-05-25

SELENE

Phase 3 Completed

403 enrolled 23 charts

Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone